| アブストラクト | BACKGROUND: The average life expectancy for people with a severe mental illness (SMI) such as schizophrenia or bipolar disorder is 15 to 20 years less than that for the population as a whole. Diabetes contributes significantly to this inequality, being 2 to 3 times more prevalent in people with SMI. Various risk factors have been implicated, including side effects of antipsychotic medication and unhealthy lifestyles, which often occur in the context of socioeconomic disadvantage and health care inequality. However, little is known about how these factors may interact to influence the risk of developing diabetes and poor diabetic outcomes, or how the organization and provision of health care may contribute. OBJECTIVE: This study aims to identify the determinants of diabetes and to explore variation in diabetes outcomes for people with SMI. METHODS: This study will employ a concurrent mixed methods design combining the interrogation of electronic primary care health records from the Clinical Practice Research Datalink (CPRD GOLD) with qualitative interviews with adults with SMI and diabetes, their relatives and friends, and health care staff. The study has been funded for 2 years, from September 2017 to September 2019, and data collection has recently ended. RESULTS: CPRD and linked health data will be used to explore the association of sociodemographics, illness, and health care-related factors with both the development and outcomes of type 2 diabetes in people with SMI. Experiences of managing the comorbidity and accessing health care will be explored through qualitative interviews using topic guides informed by evidence synthesis and expert consultation. Findings from both datasets will be merged to develop a more comprehensive understanding of diabetes risks, interventions, and outcomes for people with SMI. Findings will be translated into recommendations for interventions and services using co-design workshops. CONCLUSIONS: Improving diabetes outcomes for people with SMI is a high-priority area nationally and globally. Understanding how risk factors combine to generate high prevalence of diabetes and poor diabetic outcomes for this population is a necessary first step in developing health care interventions to improve outcomes for people with diabetes and SMI. TRIAL REGISTRATION: ClinicalTrials.gov NCT03534921; https://clinicaltrials.gov/ct2/show/NCT03534921. |
|---|
| ジャーナル名 | JMIR research protocols |
|---|
| Pubmed追加日 | 2019/9/8 |
|---|
| 投稿者 | Bellass, Sue; Taylor, Johanna; Han, Lu; Prady, Stephanie L; Shiers, David; Jacobs, Rowena; Holt, Richard Ian Gregory; Radford, John; Gilbody, Simon; Hewitt, Catherine; Doran, Tim; Alderson, Sarah L; Siddiqi, Najma |
|---|
| 組織名 | Mental Health and Addiction Research Group, Department of Health Sciences,;University of York, York, United Kingdom.;Department of Health Sciences, University of York, York, United Kingdom.;Psychosis Research Unit, Prestwich Hospital, Greater Manchester Mental Health NHS;Foundation Trust & The University of Manchester, Manchester, United Kingdom.;University of Keele, Keele, United Kingdom.;Centre for Health Economics, Department of Health Sciences, University of York,;York, United Kingdom.;Faculty of Medicine, University of Southampton, Southampton, United Kingdom.;DIAMONDS VOICE Patient and Public Involvement Panel, Bradford District Care NHS;Foundation Trust, Bradford, Bradford, United Kingdom.;York Trials Unit, Department of Health Sciences, University of York, York, United;Kingdom.;Faculty of Medicine and Health, University of Leeds, Leeds, United Kingdom. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/31493324/ |
|---|
